vs
Orthofix Medical Inc.（OFIX）与RADIANT LOGISTICS, INC（RLGT）财务数据对比。点击上方公司名可切换其他公司
RADIANT LOGISTICS, INC的季度营收约是Orthofix Medical Inc.的1.1倍（$232.1M vs $219.9M），RADIANT LOGISTICS, INC净利率更高（2.3% vs -1.0%，领先3.3%），Orthofix Medical Inc.同比增速更快（2.0% vs -12.3%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $11.6M），过去两年RADIANT LOGISTICS, INC的营收复合增速更高（12.1% vs 8.0%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
Radiant Logistics, Inc.是一家知名第三方物流服务商，提供端到端供应链解决方案、国内外货运代理、仓储及末端配送服务，核心市场覆盖北美，客户涵盖零售、制造、电商、工业等多个领域，助力企业优化物流流程、降低运营成本。
OFIX vs RLGT — 直观对比
营收规模更大
RLGT
是对方的1.1倍
$219.9M
营收增速更快
OFIX
高出14.2%
-12.3%
净利率更高
RLGT
高出3.3%
-1.0%
自由现金流更多
OFIX
多$5.2M
$11.6M
两年增速更快
RLGT
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $232.1M |
| 净利润 | $-2.2M | $5.3M |
| 毛利率 | 71.1% | — |
| 营业利润率 | 0.2% | 3.2% |
| 净利率 | -1.0% | 2.3% |
| 营收同比 | 2.0% | -12.3% |
| 净利润同比 | 92.4% | -18.0% |
| 每股收益（稀释后） | $-0.05 | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXRLGT
| Q4 25 | $219.9M | $232.1M | ||
| Q3 25 | $205.6M | $226.7M | ||
| Q2 25 | $203.1M | $220.6M | ||
| Q1 25 | $193.6M | $214.0M | ||
| Q4 24 | $215.7M | $264.5M | ||
| Q3 24 | $196.6M | $203.6M | ||
| Q2 24 | $198.6M | $206.0M | ||
| Q1 24 | $188.6M | $184.6M |
净利润OFIXRLGT
| Q4 25 | $-2.2M | $5.3M | ||
| Q3 25 | $-22.8M | $1.3M | ||
| Q2 25 | $-14.1M | $4.9M | ||
| Q1 25 | $-53.1M | $2.5M | ||
| Q4 24 | $-29.1M | $6.5M | ||
| Q3 24 | $-27.4M | $3.4M | ||
| Q2 24 | $-33.4M | $4.8M | ||
| Q1 24 | $-36.0M | $-703.0K |
毛利率OFIXRLGT
| Q4 25 | 71.1% | — | ||
| Q3 25 | 72.2% | — | ||
| Q2 25 | 68.7% | — | ||
| Q1 25 | 62.8% | — | ||
| Q4 24 | 69.0% | — | ||
| Q3 24 | 68.7% | — | ||
| Q2 24 | 67.8% | — | ||
| Q1 24 | 67.5% | — |
营业利润率OFIXRLGT
| Q4 25 | 0.2% | 3.2% | ||
| Q3 25 | -8.3% | 0.9% | ||
| Q2 25 | -7.9% | 2.4% | ||
| Q1 25 | -25.2% | 1.6% | ||
| Q4 24 | -5.3% | 3.3% | ||
| Q3 24 | -9.6% | 1.9% | ||
| Q2 24 | -12.5% | 2.4% | ||
| Q1 24 | -15.6% | -0.5% |
净利率OFIXRLGT
| Q4 25 | -1.0% | 2.3% | ||
| Q3 25 | -11.1% | 0.6% | ||
| Q2 25 | -6.9% | 2.2% | ||
| Q1 25 | -27.4% | 1.2% | ||
| Q4 24 | -13.5% | 2.4% | ||
| Q3 24 | -13.9% | 1.7% | ||
| Q2 24 | -16.8% | 2.3% | ||
| Q1 24 | -19.1% | -0.4% |
每股收益（稀释后）OFIXRLGT
| Q4 25 | $-0.05 | $0.11 | ||
| Q3 25 | $-0.57 | $0.03 | ||
| Q2 25 | $-0.36 | $0.10 | ||
| Q1 25 | $-1.35 | $0.05 | ||
| Q4 24 | $-0.76 | $0.13 | ||
| Q3 24 | $-0.71 | $0.07 | ||
| Q2 24 | $-0.88 | $0.11 | ||
| Q1 24 | $-0.95 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $31.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $450.0M | $229.8M |
| 总资产 | $850.6M | $439.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资OFIXRLGT
| Q4 25 | $82.0M | $31.9M | ||
| Q3 25 | $62.9M | $28.1M | ||
| Q2 25 | $65.6M | $22.9M | ||
| Q1 25 | $58.0M | $19.0M | ||
| Q4 24 | $83.2M | $19.9M | ||
| Q3 24 | $30.1M | $10.4M | ||
| Q2 24 | $26.4M | $24.9M | ||
| Q1 24 | $27.0M | $31.2M |
总债务OFIXRLGT
| Q4 25 | — | — | ||
| Q3 25 | $157.2M | — | ||
| Q2 25 | $157.0M | — | ||
| Q1 25 | $156.9M | — | ||
| Q4 24 | $157.0M | — | ||
| Q3 24 | $118.5M | — | ||
| Q2 24 | $118.0M | — | ||
| Q1 24 | $118.2M | — |
股东权益OFIXRLGT
| Q4 25 | $450.0M | $229.8M | ||
| Q3 25 | $442.5M | $225.7M | ||
| Q2 25 | $458.3M | $226.0M | ||
| Q1 25 | $458.3M | $218.2M | ||
| Q4 24 | $503.1M | $214.4M | ||
| Q3 24 | $525.9M | $212.4M | ||
| Q2 24 | $546.0M | $209.4M | ||
| Q1 24 | $570.3M | $206.0M |
总资产OFIXRLGT
| Q4 25 | $850.6M | $439.4M | ||
| Q3 25 | $832.6M | $445.3M | ||
| Q2 25 | $837.2M | $426.8M | ||
| Q1 25 | $823.1M | $414.5M | ||
| Q4 24 | $893.3M | $386.8M | ||
| Q3 24 | $867.9M | $375.3M | ||
| Q2 24 | $882.0M | $371.2M | ||
| Q1 24 | $906.0M | $364.0M |
负债/权益比OFIXRLGT
| Q4 25 | — | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.23× | — | ||
| Q2 24 | 0.22× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $12.4M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $11.6M |
| 自由现金流率自由现金流/营收 | 7.6% | 5.0% |
| 资本支出强度资本支出/营收 | 4.9% | 0.3% |
| 现金转化率经营现金流/净利润 | — | 2.33× |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $8.5M |
8季度趋势，按日历期对齐
经营现金流OFIXRLGT
| Q4 25 | $27.7M | $12.4M | ||
| Q3 25 | $12.4M | $2.5M | ||
| Q2 25 | $11.6M | $3.1M | ||
| Q1 25 | $-18.4M | $-5.7M | ||
| Q4 24 | $23.7M | $15.7M | ||
| Q3 24 | $11.7M | $205.0K | ||
| Q2 24 | $9.0M | $1.3M | ||
| Q1 24 | $-18.6M | $3.9M |
自由现金流OFIXRLGT
| Q4 25 | $16.8M | $11.6M | ||
| Q3 25 | $2.5M | $977.0K | ||
| Q2 25 | $4.5M | $2.2M | ||
| Q1 25 | $-25.1M | $-6.4M | ||
| Q4 24 | $15.2M | $14.1M | ||
| Q3 24 | $6.3M | $-1.9M | ||
| Q2 24 | $-360.0K | $-185.0K | ||
| Q1 24 | $-29.1M | $1.8M |
自由现金流率OFIXRLGT
| Q4 25 | 7.6% | 5.0% | ||
| Q3 25 | 1.2% | 0.4% | ||
| Q2 25 | 2.2% | 1.0% | ||
| Q1 25 | -13.0% | -3.0% | ||
| Q4 24 | 7.0% | 5.3% | ||
| Q3 24 | 3.2% | -0.9% | ||
| Q2 24 | -0.2% | -0.1% | ||
| Q1 24 | -15.4% | 1.0% |
资本支出强度OFIXRLGT
| Q4 25 | 4.9% | 0.3% | ||
| Q3 25 | 4.8% | 0.7% | ||
| Q2 25 | 3.5% | 0.4% | ||
| Q1 25 | 3.5% | 0.3% | ||
| Q4 24 | 4.0% | 0.6% | ||
| Q3 24 | 2.7% | 1.0% | ||
| Q2 24 | 4.7% | 0.7% | ||
| Q1 24 | 5.6% | 1.2% |
现金转化率OFIXRLGT
| Q4 25 | — | 2.33× | ||
| Q3 25 | — | 1.90× | ||
| Q2 25 | — | 0.63× | ||
| Q1 25 | — | -2.26× | ||
| Q4 24 | — | 2.43× | ||
| Q3 24 | — | 0.06× | ||
| Q2 24 | — | 0.26× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
RLGT
| Transferred Over Time | $201.2M | 87% |
| Other | $25.0M | 11% |
| Value Added Services | $4.2M | 2% |
| Transferred At Point In Time | $1.8M | 1% |
